ReviewJournal of biochemical and molecular toxicology2026
Microplastics as Emerging Neurotoxins: Brain Accumulation, Neuroinflammation, and Neurodegeneration Risk.
Review in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microplastics (MPs) and nanoplastics (NPs) have emerged as ubiquitous environmental contaminants with profound implications for human neurological health. Recent landmark findings confirm the bioaccumulation of MPs/NPs in human brain tissue-with concentrations reaching 4917 μg/g in 2024 autopsy samples and up to 10-fold higher levels in individuals with dementia-underscoring the urgent need for mechanistic understanding. This review synthesizes current evidence on the routes by which MPs/NPs traverse the blood-brain barrier (BBB) and the olfactory pathway, their cellular effects within the central nervous system (CNS), and the molecular cascades that link plastic particle exposure to neuroinflammation and neurodegeneration. Key mechanisms include: disruption of tight junction proteins and BBB integrity; activation of microglia and the NLRP3 inflammasome; induction of oxidative stress via reactive oxygen species (ROS); mitochondrial dysfunction through impairment of the electron transport chain; synaptic toxicity and neurotransmitter dysregulation; and direct promotion of pathological protein aggregation-including amyloid-beta (Aβ), tau hyperphosphorylation, and α-synuclein fibrillation-implicated in Alzheimer's disease (AD) and Parkinson's disease (PD). Indirect neurotoxicity via the gut-brain axis is also addressed. Finally, critical research gaps and future directions are proposed, including standardized exposure models, longitudinal human cohort studies, and evaluation of therapeutic targets. This review positions MPs/NPs as a novel environmental risk factor for neurodegenerative diseases warranting priority attention in neuroscience and public health research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.